A prospective study of serum antibody responses to enterotoxinogenic Escherichia coli in Swedish travellers
- PMID: 3283923
- DOI: 10.3109/00365548809117219
A prospective study of serum antibody responses to enterotoxinogenic Escherichia coli in Swedish travellers
Abstract
Serological responses to relevant enterotoxinogenic Escherichia coli (ETEC) antigens were studied in 85 Swedish travellers to subtropical and tropical areas. Serum samples were collected from the travellers before and then after 3-5 weeks, i.e. within a week after return to Sweden, when a faecal specimen was also taken. 40% of the participants had traveller's diarrhoea during their visit abroad, while 21% reported "loose stools" and 39% had no such problems. ETEC was rarely isolated from the stool of any of the travellers on their return to Sweden (6%). Salmonellae, Shigellae or Campylobacter jejuni were isolated from 13 (15%) of the travellers, 12 of whom were healthy when the specimens were collected and 4 of whom had been healthy during travel as well. Significant serum antibody responses to E. coli heat-labile enterotoxin (LT) and colonization factor antigens CFA I or II were seen in 33% and 20% of the travellers, respectively. Anti-LT responses were comparable in participants with traveller's diarrhoea or "loose stools" and in the healthy ones, whereas anti-CFA responses were more frequent in those with symptomatic infections. Of 34 Swedes in a non-travelling control group none responded to LT and one to CFA I or CFA II.
Similar articles
-
Enterotoxin-producing bacteria isolated from Swedish travellers with diarrhoea.Scand J Infect Dis. 1991;23(4):473-9. doi: 10.3109/00365549109075096. Scand J Infect Dis. 1991. PMID: 1957131
-
Serum antibody responses to bacterial enteropathogens in Swedish travelers to south-east Asia.Scand J Infect Dis. 1990;22(6):699-704. doi: 10.3109/00365549009027123. Scand J Infect Dis. 1990. PMID: 2284576
-
Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea.Clin Microbiol Infect. 2011 Aug;17(8):1194-200. doi: 10.1111/j.1469-0691.2010.03414.x. Epub 2010 Dec 13. Clin Microbiol Infect. 2011. PMID: 21054662
-
Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.Lancet Infect Dis. 2014 Mar;14(3):197-204. doi: 10.1016/S1473-3099(13)70297-4. Epub 2013 Nov 29. Lancet Infect Dis. 2014. PMID: 24291168 Clinical Trial.
-
Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea.Vaccine. 1989 Jun;7(3):196-8. doi: 10.1016/0264-410x(89)90228-4. Vaccine. 1989. PMID: 2675484 Review.
Cited by
-
Infection with bacterial enteropathogens in Swedish travellers to South-East Asia--a prospective study.Epidemiol Infect. 1990 Oct;105(2):325-33. doi: 10.1017/s0950268800047920. Epidemiol Infect. 1990. PMID: 2209737 Free PMC article.
-
Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.Epidemiol Infect. 1989 Feb;102(1):47-57. doi: 10.1017/s0950268800029678. Epidemiol Infect. 1989. PMID: 2917617 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical